TP53 and neuroendocrine neoplasm: These tumors frequently exhibit inactivation of key tumor suppressor genes such as TP53 and RB1[37] These alterations are considered hallmark features of poorly differentiated neuroendocrine tumors and represent core drivers of their uncontrolled proliferation and genomic instability.